Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1995-06-07
1998-12-15
Achutamurthy, Ponnathapura
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
4241481, 4241601, 4351723, A61K 3921, A61K 3942, C12N 1500
Patent
active
058493042
ABSTRACT:
A recombinant vaccinia virus capable of expressing HTLV-III envelope protein (env) has been constructed. The expressed env protein is recognized by sera obtained from AIDS patients. The synthesized env protein also produces antibodies when administered to a suitable host, such antibodies having specific binding affinity with the env protein.
REFERENCES:
patent: 4753873 (1988-06-01), Beltz et al.
patent: 4772547 (1988-09-01), Heimer et al.
patent: 4774175 (1988-09-01), Chang et al.
patent: 5017487 (1991-05-01), Stunnenberg et al.
patent: 5081029 (1992-01-01), Zarling
Lizhong et al., Journal of Virology 62: 776-782 (Mar. 1988).
Lifson et al., Nature 323: 725-728 (Oct. 23, 1986).
Sodroski et al., Nature 321:412-417 (May 22, 1986).
Peterlin et al., Proc. Natl. Acad. Sci. USA 83: 9734-9738 (Dec. 1986).
Rosen et al., Nature 319: 555-559 (Feb. 13, 1986).
Langford et al., Molecular and Cellular Biology 6: 3191-3199 (Sep. 1986).
Berman et al., Journal of Virology 62: 3135-3142 (Sep. 1988).
Falkner et al., virology 164: 450-457 (1988).
Earl et al., Aids Research & Human Retroviruses 5(1): 23-32 (1989).
Haigwood et al., J. of Virology 66(1): 172-182 (Jan. 1992).
Hammarskjold et al., J. of Virology 63(5): 1959-1966 (May 1989).
Elango et al., Proc. Natl. Acad. Sci. USA 83:1906-1910 (1986).
Stephens et al., The Embo Journal 5: 237-245 (1986).
Mackett et al., The Embo Journal 4:3229-3234 (1985).
Robey et al., Characterization of Envelope and Core Structural Gene Products of HTLV-III with Sera from AIDS Patients, Science vol. 228, pp. 593-595, see Figure 1, May 1985.
Ratner et al., Complete nucleotide sequence of the AIDS virus, HTLV-III, Nature vol. 313, pp. 277-284, Jan. 1985.
Delente, Glycosylation revisited, Trends in Biotechnology, vol. 3, No. 9, p. 218, 1985.
Chakrabarti Sekhar
Moss Bernard
Achutamurthy Ponnathapura
Park Hankyel T.
The United States of America as represented by the Department of
LandOfFree
Recombinant vaccinia virus expressing human retrovirus gene does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant vaccinia virus expressing human retrovirus gene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant vaccinia virus expressing human retrovirus gene will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1455226